Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1

Anna Maria Rossi, Inger Lise Hansteen, Camilla Furu Skjelbred, Michela Ballardin, Valentina Maggini, Elena Murgia, Antonio Tomei, Paolo Viarengo, Lisbeth E. Knudsen, Roberto Barale, Hannu Norppa, Stefano Bonassi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: The frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of healthy individuals has been associated with cancer risk. It is presently unclear whether this association is influenced by individual susceptibility factors such as genetic polymorphisms of xenobiotic-metabolizing enzymes. Objectives: To evaluate the role of polymorphisms in glutathione S-transferase (GST) M1 (GSTM1) and theta 1 (GSTT1) as effect modifiers of the association between CA and cancer risk. Methods: A case-control study was performed pooling data from cytogenetic studies carried out in 1974-1995 in three laboratories in Italy, Norway, and Denmark. A total of 107 cancer cases were retrieved from national registries and matched to 291 controls. The subjects were classified as low, medium, and high by tertile of CA frequency. The data were analyzed by setting up a Bayesian model that included prior information about cancer risk by CA frequency. Results: The association between CA frequency and cancer risk was confirmed [ORmedium (odds ratio)medium = 1.5, 95% credibility interval (CrI), 0.9-2.5; ORhigh = 2.8, 95% CrI, 1.6-4.6], whereas no effect of the genetic polymorphism was observed. A much stronger association was seen in the Italian subset (ORhigh= 9.4, 95% CrI, 2.6-28.0), which was characterized by a lower technical variability of the cytogenetic analysis. CA level was particularly associated with cancer of the respiratory tract (ORhigh= 6.2, 95% CrI, 1.5-20.0), the genitourinary tract (ORhigh = 4.0, 95% CrI, 1.4-10.0), and the digestive tract (ORhigh = 2.8, 95% CrI, 1.2-5.8). Conclusions: Despite the small size of the study groups, our results substantiate the cancer risk predictivity of CA frequency, ruling against a strong modifying effect of GSTM1 and GSTT1 polymorphisms.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalEnvironmental Health Perspectives
Volume117
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Genetic Polymorphisms
Chromosome Aberrations
Neoplasms
Cytogenetic Analysis
Xenobiotics
Denmark
Norway
Cytogenetics
Respiratory System
Italy
Registries
Meta-Analysis
Gastrointestinal Tract
Case-Control Studies
Odds Ratio
Lymphocytes
Enzymes

Keywords

  • Bayesian
  • Biomarker
  • Cancer risk
  • Case-control study
  • Chromosomal aberration
  • Genetic polymorphism
  • Glutathione S-transferase
  • GSTM1
  • GSTT1
  • Monte Carlo Markov China

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health

Cite this

Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. / Rossi, Anna Maria; Hansteen, Inger Lise; Skjelbred, Camilla Furu; Ballardin, Michela; Maggini, Valentina; Murgia, Elena; Tomei, Antonio; Viarengo, Paolo; Knudsen, Lisbeth E.; Barale, Roberto; Norppa, Hannu; Bonassi, Stefano.

In: Environmental Health Perspectives, Vol. 117, No. 2, 2009, p. 203-208.

Research output: Contribution to journalArticle

Rossi, AM, Hansteen, IL, Skjelbred, CF, Ballardin, M, Maggini, V, Murgia, E, Tomei, A, Viarengo, P, Knudsen, LE, Barale, R, Norppa, H & Bonassi, S 2009, 'Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1', Environmental Health Perspectives, vol. 117, no. 2, pp. 203-208. https://doi.org/10.1289/ehp.11769
Rossi, Anna Maria ; Hansteen, Inger Lise ; Skjelbred, Camilla Furu ; Ballardin, Michela ; Maggini, Valentina ; Murgia, Elena ; Tomei, Antonio ; Viarengo, Paolo ; Knudsen, Lisbeth E. ; Barale, Roberto ; Norppa, Hannu ; Bonassi, Stefano. / Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1. In: Environmental Health Perspectives. 2009 ; Vol. 117, No. 2. pp. 203-208.
@article{03e6684b3e3b4d548bf3467099fc8aec,
title = "Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1",
abstract = "Background: The frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of healthy individuals has been associated with cancer risk. It is presently unclear whether this association is influenced by individual susceptibility factors such as genetic polymorphisms of xenobiotic-metabolizing enzymes. Objectives: To evaluate the role of polymorphisms in glutathione S-transferase (GST) M1 (GSTM1) and theta 1 (GSTT1) as effect modifiers of the association between CA and cancer risk. Methods: A case-control study was performed pooling data from cytogenetic studies carried out in 1974-1995 in three laboratories in Italy, Norway, and Denmark. A total of 107 cancer cases were retrieved from national registries and matched to 291 controls. The subjects were classified as low, medium, and high by tertile of CA frequency. The data were analyzed by setting up a Bayesian model that included prior information about cancer risk by CA frequency. Results: The association between CA frequency and cancer risk was confirmed [ORmedium (odds ratio)medium = 1.5, 95{\%} credibility interval (CrI), 0.9-2.5; ORhigh = 2.8, 95{\%} CrI, 1.6-4.6], whereas no effect of the genetic polymorphism was observed. A much stronger association was seen in the Italian subset (ORhigh= 9.4, 95{\%} CrI, 2.6-28.0), which was characterized by a lower technical variability of the cytogenetic analysis. CA level was particularly associated with cancer of the respiratory tract (ORhigh= 6.2, 95{\%} CrI, 1.5-20.0), the genitourinary tract (ORhigh = 4.0, 95{\%} CrI, 1.4-10.0), and the digestive tract (ORhigh = 2.8, 95{\%} CrI, 1.2-5.8). Conclusions: Despite the small size of the study groups, our results substantiate the cancer risk predictivity of CA frequency, ruling against a strong modifying effect of GSTM1 and GSTT1 polymorphisms.",
keywords = "Bayesian, Biomarker, Cancer risk, Case-control study, Chromosomal aberration, Genetic polymorphism, Glutathione S-transferase, GSTM1, GSTT1, Monte Carlo Markov China",
author = "Rossi, {Anna Maria} and Hansteen, {Inger Lise} and Skjelbred, {Camilla Furu} and Michela Ballardin and Valentina Maggini and Elena Murgia and Antonio Tomei and Paolo Viarengo and Knudsen, {Lisbeth E.} and Roberto Barale and Hannu Norppa and Stefano Bonassi",
year = "2009",
doi = "10.1289/ehp.11769",
language = "English",
volume = "117",
pages = "203--208",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "2",

}

TY - JOUR

T1 - Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1

AU - Rossi, Anna Maria

AU - Hansteen, Inger Lise

AU - Skjelbred, Camilla Furu

AU - Ballardin, Michela

AU - Maggini, Valentina

AU - Murgia, Elena

AU - Tomei, Antonio

AU - Viarengo, Paolo

AU - Knudsen, Lisbeth E.

AU - Barale, Roberto

AU - Norppa, Hannu

AU - Bonassi, Stefano

PY - 2009

Y1 - 2009

N2 - Background: The frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of healthy individuals has been associated with cancer risk. It is presently unclear whether this association is influenced by individual susceptibility factors such as genetic polymorphisms of xenobiotic-metabolizing enzymes. Objectives: To evaluate the role of polymorphisms in glutathione S-transferase (GST) M1 (GSTM1) and theta 1 (GSTT1) as effect modifiers of the association between CA and cancer risk. Methods: A case-control study was performed pooling data from cytogenetic studies carried out in 1974-1995 in three laboratories in Italy, Norway, and Denmark. A total of 107 cancer cases were retrieved from national registries and matched to 291 controls. The subjects were classified as low, medium, and high by tertile of CA frequency. The data were analyzed by setting up a Bayesian model that included prior information about cancer risk by CA frequency. Results: The association between CA frequency and cancer risk was confirmed [ORmedium (odds ratio)medium = 1.5, 95% credibility interval (CrI), 0.9-2.5; ORhigh = 2.8, 95% CrI, 1.6-4.6], whereas no effect of the genetic polymorphism was observed. A much stronger association was seen in the Italian subset (ORhigh= 9.4, 95% CrI, 2.6-28.0), which was characterized by a lower technical variability of the cytogenetic analysis. CA level was particularly associated with cancer of the respiratory tract (ORhigh= 6.2, 95% CrI, 1.5-20.0), the genitourinary tract (ORhigh = 4.0, 95% CrI, 1.4-10.0), and the digestive tract (ORhigh = 2.8, 95% CrI, 1.2-5.8). Conclusions: Despite the small size of the study groups, our results substantiate the cancer risk predictivity of CA frequency, ruling against a strong modifying effect of GSTM1 and GSTT1 polymorphisms.

AB - Background: The frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of healthy individuals has been associated with cancer risk. It is presently unclear whether this association is influenced by individual susceptibility factors such as genetic polymorphisms of xenobiotic-metabolizing enzymes. Objectives: To evaluate the role of polymorphisms in glutathione S-transferase (GST) M1 (GSTM1) and theta 1 (GSTT1) as effect modifiers of the association between CA and cancer risk. Methods: A case-control study was performed pooling data from cytogenetic studies carried out in 1974-1995 in three laboratories in Italy, Norway, and Denmark. A total of 107 cancer cases were retrieved from national registries and matched to 291 controls. The subjects were classified as low, medium, and high by tertile of CA frequency. The data were analyzed by setting up a Bayesian model that included prior information about cancer risk by CA frequency. Results: The association between CA frequency and cancer risk was confirmed [ORmedium (odds ratio)medium = 1.5, 95% credibility interval (CrI), 0.9-2.5; ORhigh = 2.8, 95% CrI, 1.6-4.6], whereas no effect of the genetic polymorphism was observed. A much stronger association was seen in the Italian subset (ORhigh= 9.4, 95% CrI, 2.6-28.0), which was characterized by a lower technical variability of the cytogenetic analysis. CA level was particularly associated with cancer of the respiratory tract (ORhigh= 6.2, 95% CrI, 1.5-20.0), the genitourinary tract (ORhigh = 4.0, 95% CrI, 1.4-10.0), and the digestive tract (ORhigh = 2.8, 95% CrI, 1.2-5.8). Conclusions: Despite the small size of the study groups, our results substantiate the cancer risk predictivity of CA frequency, ruling against a strong modifying effect of GSTM1 and GSTT1 polymorphisms.

KW - Bayesian

KW - Biomarker

KW - Cancer risk

KW - Case-control study

KW - Chromosomal aberration

KW - Genetic polymorphism

KW - Glutathione S-transferase

KW - GSTM1

KW - GSTT1

KW - Monte Carlo Markov China

UR - http://www.scopus.com/inward/record.url?scp=60749121861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749121861&partnerID=8YFLogxK

U2 - 10.1289/ehp.11769

DO - 10.1289/ehp.11769

M3 - Article

VL - 117

SP - 203

EP - 208

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 2

ER -